| VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs | Sarah de Crescenzo | 07/09/20 | San Diego |
| Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine | Sarah de Crescenzo | 07/07/20 | National |
| PacBio CEO, CFO Plan Retirements and More People on the Move | Editors | 07/07/20 | National |
| MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy | Sarah de Crescenzo | 07/02/20 | San Diego |
| Roche Gets FDA OK for Injectable Version of Breast Cancer Drug | Sarah de Crescenzo | 06/29/20 | San Diego |
| FDA Again Dings Heron’s Opioid Alternative Over “Nonclinical Issues” | Sarah de Crescenzo | 06/29/20 | San Diego |
| Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies | Sarah de Crescenzo | 06/26/20 | San Diego |
| Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More | Sarah de Crescenzo | 06/26/20 | National |
| La Jolla Pharma Steps In With Better Offer, Wins Tetraphase Bidding War | Frank Vinluan | 06/24/20 | San Diego |
| Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease | Sarah de Crescenzo | 06/23/20 | San Diego |
| Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More | Frank Vinluan | 06/19/20 | National |
| Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs | Sarah de Crescenzo | 06/18/20 | San Diego |
| Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer | Sarah de Crescenzo | 06/17/20 | San Diego |
| Exec Search Underway at PacBio After CEO, CFO Announce Plans to Retire | Sarah de Crescenzo | 06/16/20 | San Francisco |
| FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 | Sarah de Crescenzo | 06/15/20 | National |
| Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More | Sarah de Crescenzo | 06/12/20 | National |
| Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine | Frank Vinluan | 06/11/20 | Boston |
| Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic | Frank Vinluan | 06/08/20 | Boston |
| Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More | Frank Vinluan | 06/05/20 | National |
| AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds | Frank Vinluan | 05/29/20 | National |
| Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More | Sarah de Crescenzo | 05/29/20 | National |
| New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech | Editors | 05/27/20 | Boston |
| Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments | Sarah de Crescenzo | 05/26/20 | San Diego |
| Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq | Frank Vinluan | 05/22/20 | National |
| FDA Approves Evofem’s “On-Demand” Non-Hormonal Birth Control Gel | Sarah de Crescenzo | 05/22/20 | National |
| Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More | Frank Vinluan | 05/22/20 | National |
| Vividion Gets $135M in Collaboration With Roche on Protein Degradation | Sarah de Crescenzo | 05/20/20 | San Diego |
| Explore San Diego’s Precision Medicine and Genomics Sector in Xconomy’s New Podcast and Special Report | Editors | 05/20/20 | National |
| Amplyx Adds Cash from Pfizer, Adage as Funding Round Tops $90M | Sarah de Crescenzo | 05/19/20 | San Diego |
| Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More | Sarah de Crescenzo | 05/15/20 | National |
